Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,125,160    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,064,010      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 23 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-12 4 D $121.09 $284,440 D/D (2,349) 240,826 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-08-15 4 AS $95.21 $285,630 D/D (3,000) 328,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-02-28 4 AS $58.00 $290,000 I/I (5,000) 18,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-24 4 AS $48.38 $290,252 D/D (6,000) 178,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-22 4 AS $96.82 $290,460 D/D (3,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Business Officer   •       •      –    2012-05-12 5 D $38.00 $297,160 D/D (7,820) 149,446 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-04 4 AS $60.00 $300,000 I/I (5,000) 13,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-09 4 S $38.39 $310,031 D/D (8,000) 8,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-08 4 D $56.78 $311,098 D/D (5,479) 189,756 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-11-05 4 AS $62.36 $311,779 I/I (5,000) 45,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-17 4 OE $64.01 $320,050 I/I 5,000 30,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-26 4 AS $80.50 $322,000 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-02 4 AS $107.96 $323,893 I/I (3,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-14 4 OE $12.99 $324,750 I/I 25,000 45,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-09 4 AS $81.97 $327,888 D/D (4,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-08 4 AS $82.16 $328,625 D/D (4,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-30 4 AS $83.35 $333,400 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-29 4 AS $83.84 $335,360 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-26 4 AS $48.38 $338,633 D/D (7,000) 171,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-08 4 AS $84.92 $339,680 D/D (4,000) 327,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-01-02 4 AS $68.90 $344,483 I/I (5,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-10-25 4 AS $69.55 $347,750 D/D (5,000) 327,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-11-10 4 S $87.00 $348,000 I/I (4,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-12-05 4 AS $69.70 $348,485 I/I (5,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-06 4 AS $87.19 $348,760 D/D (4,000) 170,682 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23  24   25   26   27   28   29   30   31   32   33   34      
  Page 23 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us